AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2022 Earnings Call Transcript

AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2022 Earnings Call Transcript February 21, 2023

Operator: Good afternoon. And welcome to AbCellera’s Full-Year 2022 Business Update Conference Call. My name is Daniel, and I will facilitate the audio portion of today’s interactive broadcast. At this time, I would like to turn the call over to Tryn Stimart, AbCellera’s Chief Legal and Compliance Officer. Please proceed.

Tryn Stimart: Thank you. Good afternoon, and welcome to AbCellera’s full-year and...